Full approval could make the difference for the US COVID-19 vaccine campaign

Link will be apear in 15 seconds.

Well done! you have successfully gained access to Decrypted Link.

Anyone who is interested in a COVID-19 vaccination in the United States should now receive a detailed information sheet. The information sheet informs them that the vaccine is technically not approved for use in the United States, even though it can prevent COVID-19.

Instead, people get the shot under an Emergency Use Authorization (EUA). This designation allows the Food and Drug Administration to sign off on life-saving immunizations, without having to go through lengthy licensing processes. They were still subject to a strict safety review and are highly effective.

Some people may not be vaccinated because of the "emergency", or the fact that shots have yet to be approved. The Kaiser Family Foundation has released new polling that shows that about a third of Americans who are not vaccinated would be more likely get them vaccinated if the FDA approves the shots. A third of Americans are not currently vaccinated. This would mean that around 35 percent of the population is unvaccinated. The US adult population makes up about 10 percent.

An increase of 10 percent in vaccinations would be significant for Americans, particularly as the Delta coronavirus spreads across the country. It is highly contagious and is quickly spreading to communities that don't have the vaccine. For example, in Missouri, low-vaccination counties are experiencing spikes in COVID-19 hospitalizations.

Experts warned last summer that emergency use of COVID-19 vaccines, even though they were the best way to fight the pandemic could cause some vaccine hesitancy. Their limited data back then was not encouraging. Only around 8 percent of respondents said they would take an emergency H1N1 vaccine in 2009. Although people were less likely to receive an emergency COVID-19 vaccination, some still have reservations. Every person who refuses to take the COVID-19 vaccination is an indication of weakness in US protection against the disease.

While the FDA is reviewing both Moderna and Pfizer/BioNTech COVID-19 applications, it's not yet clear when the final license will be issued. Public health officials continue to use every tool they have to encourage more people to become vaccinated. This includes mobile clinics and lotteries. Although full approval is likely to be a significant boost in vaccination numbers, Delta is already here -- so there's no need to wait.